Eiko LifeSciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	527.07	376.64	279.29	183.21	254.12
Other Revenue	9.73	-0	-	-	-
Revenue	536.79	376.64	279.29	183.21	254.12
Revenue Growth (YoY)	42.52%	34.85%	52.44%	-27.90%	111.93%
Cost of Revenue	412.95	328.05	254.16	161.14	226.16
Gross Profit	123.84	48.59	25.14	22.07	27.96
Selling, General & Admin	6.66	7.23	2.73	3.68	2.82
Other Operating Expenses	33.07	13.76	6.28	8.85	11.98
Operating Expenses	49.9	28.36	15.63	18.85	20.42
Operating Income	73.94	20.23	9.5	3.22	7.53
Interest Expense	-3.3	-1.53	-1.42	-1.5	-3.69
Interest & Investment Income	-	6.93	1.82	7.27	6.42
Earnings From Equity Investments	0.53	1.43	-	-	-
Currency Exchange Gain (Loss)	-	0.03	-0.06	0.96	0.11
Other Non Operating Income (Expenses)	-	-0.06	-0	0	-0.95
EBT Excluding Unusual Items	71.18	27.04	9.84	9.95	9.42
Gain (Loss) on Sale of Investments	-	0.2	-	0.32	-
Gain (Loss) on Sale of Assets	-	0	-	-	-
Other Unusual Items	-	3.41	-	-	-
Pretax Income	71.18	30.65	9.84	10.26	9.42
Income Tax Expense	17.93	7.46	2.33	2.58	2.36
Earnings From Continuing Operations	53.25	23.19	7.52	7.69	7.06
Minority Interest in Earnings	-8.28	-2.13	-	-	-
Net Income	44.96	21.06	7.52	7.69	7.06
Net Income to Common	44.96	21.06	7.52	7.69	7.06
Net Income Growth	113.53%	180.20%	-2.25%	8.94%	14.88%
Shares Outstanding (Basic)	14	13	10	10	8
Shares Outstanding (Diluted)	14	13	10	10	8
Shares Change (YoY)	8.12%	26.37%	5.41%	25.30%	104.48%
EPS (Basic)	3.26	1.62	0.73	0.79	0.90
EPS (Diluted)	3.19	1.62	0.73	0.79	0.90
EPS Growth	97.49%	121.73%	-7.26%	-12.72%	-44.03%
Free Cash Flow	22.84	-73.67	-74.26	39.99	-78.82
Free Cash Flow Per Share	1.62	-5.65	-7.20	4.09	-10.09
Gross Margin	23.07%	12.90%	9.00%	12.05%	11.00%
Operating Margin	13.78%	5.37%	3.40%	1.76%	2.96%
Profit Margin	8.38%	5.59%	2.69%	4.20%	2.78%
Free Cash Flow Margin	4.25%	-19.56%	-26.59%	21.83%	-31.02%
EBITDA	84.1	27.6	16.13	9.55	13.16
EBITDA Margin	15.67%	7.33%	5.78%	5.21%	5.18%
D&A For EBITDA	10.16	7.37	6.63	6.33	5.62
EBIT	73.94	20.23	9.5	3.22	7.53
EBIT Margin	13.78%	5.37%	3.40%	1.76%	2.96%
Effective Tax Rate	25.19%	24.35%	23.64%	25.09%	25.09%
Revenue as Reported	536.79	383.8	281.05	191.76	260.85
Advertising Expenses	-	0.06	0.1	0.06	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.